Ambu A/S (OTCMKTS:AMBBY) Hits New 12-Month Low – Should You Sell?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) shares reached a new 52-week low during trading on Friday . The company traded as low as $9.5750 and last traded at $9.5750, with a volume of 3251 shares. The stock had previously closed at $9.7750.

Ambu A/S Price Performance

The company has a debt-to-equity ratio of 0.08, a current ratio of 2.86 and a quick ratio of 1.67. The company has a 50-day moving average price of $10.57 and a 200-day moving average price of $12.49. The firm has a market capitalization of $2.25 billion, a PE ratio of 34.20 and a beta of 1.06.

Ambu A/S (OTCMKTS:AMBBY) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.07 earnings per share (EPS) for the quarter. Ambu A/S had a return on equity of 8.13% and a net margin of 7.81%.The business had revenue of $246.39 million for the quarter.

Ambu A/S Company Profile

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.